Cargando…
Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction
The contribution of environmental factors to pancreatic islet damage in type 1 diabetes remains poorly understood. In this study, we crossed mice susceptible to type 1 diabetes, where parental male (CD8(+) T cells specific for IGRP(206-214); NOD8.3) and female (NOD/ShiLt) mice were randomized to a d...
Autores principales: | Borg, Danielle J., Yap, Felicia Y. T., Keshvari, Sahar, Simmons, David G., Gallo, Linda A., Fotheringham, Amelia K., Zhuang, Aowen, Slattery, Robyn M., Hasnain, Sumaira Z., Coughlan, Melinda T., Kantharidis, Phillip, Forbes, Josephine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796486/ https://www.ncbi.nlm.nih.gov/pubmed/29157116 http://dx.doi.org/10.1080/19382014.2017.1405189 |
Ejemplares similares
-
The AGE receptor, OST48 drives podocyte foot process effacement and basement membrane expansion (alters structural composition)
por: Zhuang, Aowen, et al.
Publicado: (2021) -
Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?
por: Fotheringham, Amelia K., et al.
Publicado: (2022) -
Advanced Glycation End Products Are Direct Modulators of β-Cell Function
por: Coughlan, Melinda T., et al.
Publicado: (2011) -
The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse
por: Borg, Danielle J., et al.
Publicado: (2017) -
Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion
por: Zhuang, Aowen, et al.
Publicado: (2019)